|
Sociology
Citations 901-910 of 8700 total displayed.
|
Past content
(since Oct 1840):
|
-
- News
- London Olympics are unlikely to have beneficial public health legacy, peers hear
- Adrian O’Dowd
-
BMJ 2012;344:e4202, doi: 10.1136/bmj.e4202,
-
[Extract]
[Full text]
[PDF]
-
- Editorials
- Beyond diagnosis: rising to the multimorbidity challenge
- Dee Mangin, Iona Heath, and Marc Jamoulle
-
BMJ 2012;344:e3526, doi: 10.1136/bmj.e3526,
-
[Extract]
[Full text]
[PDF]
-
- Analysis
- Post-marketing observational trials and catastrophic health expenditure
- John S Yudkin
-
BMJ 2012;344:e3987, doi: 10.1136/bmj.e3987,
-
[Extract]
[Full text]
[PDF]
-
- News
- Anticounterfeiting agreement will hinder trade in generic drugs, protesters say
- Matthew Limb
-
BMJ 2012;344:e4073, doi: 10.1136/bmj.e4073,
-
[Extract]
[Full text]
[PDF]
-
- Editorials
- People and planet: from vicious cycle to virtuous circle
- David Pencheon
-
BMJ 2012;344:e3774, doi: 10.1136/bmj.e3774,
-
[Extract]
[Full text]
[PDF]
-
- News
- Drug companies and publishers set out 10 steps to enhance credibility of industry sponsored trials
- Bob Roehr
-
BMJ 2012;344:e3767, doi: 10.1136/bmj.e3767,
-
[Extract]
[Full text]
[PDF]
-
- News
- Plan to stimulate research in developing countries is put on hold
- Anne Gulland
-
BMJ 2012;344:e3771, doi: 10.1136/bmj.e3771,
-
[Extract]
[Full text]
[PDF]
-
- Clinical review
- Restless legs syndrome
- Guy Leschziner and Paul Gringras
-
BMJ 2012;344:e3056, doi: 10.1136/bmj.e3056,
-
[Extract]
[Full text]
[PDF]
-
- News
- Full results on risks of epoetin emerge 14 years after major dialysis study
- Keith Epstein
-
BMJ 2012;344:e3535, doi: 10.1136/bmj.e3535,
-
[Extract]
[Full text]
[PDF]
-
- Feature
- Why the exclusion of older people from clinical research must stop
- Geoff Watts
-
BMJ 2012;344:e3445, doi: 10.1136/bmj.e3445,
-
[Extract]
[Full text]
[PDF]
|
